PURA PPS Periodic Surge Bolstered By Post COVID-19 Market Rally
New
York, NY -- February 25,
2020 -- via NextBigTicker.com
Puration, Inc. (USOTC:PURA)
opened up today from yesterday’s close as the PPS continues to show
signs that it could potentially experience one of its historic
periodic PPS surges. PURA hit $0.09 last September after
trading in the $0.04 range days prior. Last March, PURA hit
$0.15 after trading in the $0.06 range days prior. Yesterday,
PURA received a BUY recommendation from
AmericanBulls, a BULLISH rating from
BullishInvestor and a VERY BULLISH rating from
StockTA. Though the PPS did not see a strong increase
yesterday, it did manage to maintain its $0.03 range and not lose
any ground in one of the biggest market wide down day performances
in the last two years. With the market recovering today from
yesterday’s COVID-19 reaction, PURA is again well positioned to see
the PPS continue to climb.
The
PURA PPS recently experienced a retrace from just shy of $0.05 to
$0.03. The retrace was a healthy consolidation with less than
half the volume of the climb the week earlier. PURA is
showing clear signs that is ready to restart one if its periodic
breakout climbs that could see the PPS run back to its $0.15
52-week high. A PURA PPS accelerated climb could be triggered
at any moment news from the company’s recently launched acquisition
campaign.
MarketWatch
“U.S. stocks rallied
at the market open Tuesday as investors attempted to assess growing
headwinds like the spread of COVID-19 outside China against the
backdrop of positive economic
growth.
Global stocks were
hammered Monday, with the Dow Jones Industrial Average and S&P
500 index charting their biggest one-day percentage losses in more
than two years.”
PURA has recently launched an acquisition
campaign fueled by a $5 million investment. The company has
announced that it expects to close the acquisition of a CBD Infused
Pet Products operation later this week.
Analyst Speculative Buy and $0.35 PPS
Target
PURA recently
announced a next iteration of an ongoing CBD consumer survey
conducted by Goldman Research on behalf of PURA to gauge and refine
the company’s ongoing approach to the CBD consumer
market.
The Goldman CBD consumer survey included a PURA
speculative BUY recommendation and at $0.35 target PPS. PURA
closed yesterday at $0.29. Realizing the target PPS could
deliver a 1000% ROI. |
The full CBD consumer
survey update can be viewed at GOLDMAN CBD
SURVEY.
Other cannabis stocks that appear to be enjoying
today’s rally include Hemp (HEMP),
Medical Marijuana (MJNA)
and KushCo Holdings, (KSHB).
Disclaimer:
NextBigTicker.com (NBT)is a
third party publisher and news dissemination service
provider. NBT is NOT affiliated in any manner with any company
mentioned herein. NBT is news dissemination solutions provider and
are NOT a registered broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to sell or offer to buy
any security. NBT's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or
hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted
as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed
financial professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur.
Source: www.nextbigticker.com
Medical Marijuana (PK) (USOTC:MJNA)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Medical Marijuana (PK) (USOTC:MJNA)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
Medical Marijuana Inc (PK) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Medical Marijuana Inc (PK) News Articles